1. FritzGR, KnobilE (1963) In Vitro Stimulation by Insulin of Alpha-Amino-Isobutyric Acid Transport in the Absence of Protein Synthesis. Nature 200: 682.
2. KrahlME (1962) Insulin and protein synthesis in isolated tissues. Diabetes 11: 144–146.
3. ThomasG, Martin-PerezJ, SiegmannM, OttoAM (1982) The effect of serum, EGF, PGF2 alpha and insulin on S6 phosphorylation and the initiation of protein and DNA synthesis. Cell 30: 235–242.
4. GressnerAM, WoolIG (1976) Effect of experimental diabetes and insulin on phosphorylation of rat liver ribosomal protein S6. Nature 259: 148–150.
5. KimballSR, JurasinskiCV, LawrenceJCJr, JeffersonLS (1997) Insulin stimulates protein synthesis in skeletal muscle by enhancing the association of eIF-4E and eIF-4G. Am J Physiol 272: C754–759.
6. FleckA, ShepherdJ, MunroHN (1965) Protein synthesis in rat liver: influence of amino acids in diet on microsomes and polysomes. Science 150: 628–629.
7. HaraK, YonezawaK, WengQP, KozlowskiMT, BelhamC, et al. (1998) Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J Biol Chem 273: 14484–14494.
8. MaXM, BlenisJ (2009) Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10: 307–318.
9. HayN, SonenbergN (2004) Upstream and downstream of mTOR. Genes Dev 18: 1926–1945.
10. KimballSR, JeffersonLS (2005) Role of amino acids in the translational control of protein synthesis in mammals. Semin Cell Dev Biol 16: 21–27.
11. BolsterDR, CrozierSJ, KimballSR, JeffersonLS (2002) AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem 277: 23977–23980.
12. HolcikM, SonenbergN (2005) Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 6: 318–327.
13. WilliamsBR (2001) Signal integration via PKR. Sci STKE 2001: re2.
14. HardingHP, RonD (2002) Endoplasmic reticulum stress and the development of diabetes: a review. Diabetes 51 Suppl 3: S455–461.
15. ScheperGC, van der KnaapMS, ProudCG (2007) Translation matters: protein synthesis defects in inherited disease. Nat Rev Genet 8: 711–723.
16. KhamzinaL, VeilleuxA, BergeronS, MaretteA (2005) Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 146: 1473–1481.
17. FeligP, MarlissE, CahillGFJr (1969) Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 281: 811–816.
18. HotamisligilGS (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140: 900–917.
19. JeffersonLS, LiaoWS, PeavyDE, MillerTB, AppelMC, et al. (1983) Diabetes-induced alterations in liver protein synthesis. Changes in the relative abundance of mRNAs for albumin and other plasma proteins. J Biol Chem 258: 1369–1375.
20. AndersonSR, GilgeDA, SteiberAL, PrevisSF (2008) Diet-induced obesity alters protein synthesis: tissue-specific effects in fasted versus fed mice. Metabolism 57: 347–354.
21. KentJD, KimballSR, JeffersonLS (1991) Effect of diabetes and insulin treatment of diabetic rats on total RNA, poly(A)+ RNA, and mRNA in skeletal muscle. Am J Physiol 260: C409–416.
22. GuilletC, DelcourtI, RanceM, GiraudetC, WalrandS, et al. (2009) Changes in basal and insulin and amino acid response of whole body and skeletal muscle proteins in obese men. J Clin Endocrinol Metab 94: 3044–3050.
23. PeavyDE, TaylorJM, JeffersonLS (1978) Correlation of albumin production rates and albumin mRNA levels in livers of normal, diabetic, and insulin-treated diabetic rats. Proc Natl Acad Sci U S A 75: 5879–5883.
24. KatsanosCS, MandarinoLJ (2011) Protein metabolism in human obesity: a shift in focus from whole-body to skeletal muscle. Obesity (Silver Spring) 19: 469–475.
25. MacotelaY, EmanuelliB, BangAM, EspinozaDO, BoucherJ, et al. (2011) Dietary leucine–an environmental modifier of insulin resistance acting on multiple levels of metabolism. PLoS ONE 6: e21187 doi:10.1371/journal.pone.0021187.
26. OyadomariS, HardingHP, ZhangY, OyadomariM, RonD (2008) Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice. Cell Metab 7: 520–532.
27. PyhtilaB, ZhengT, LagerPJ, KeeneJD, ReedyMC, et al. (2008) Signal sequence- and translation-independent mRNA localization to the endoplasmic reticulum. RNA 14: 445–453.
28. FuS, YangL, LiP, HofmannO, DickerL, et al. (2011) Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 473: 528–531.
29. GregorMF, YangL, FabbriniE, MohammedBS, EagonJC, et al. (2009) Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes 58: 693–700.
30. OzcanU, CaoQ, YilmazE, LeeAH, IwakoshiNN, et al. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306: 457–461.
31. Huang daW, ShermanBT, LempickiRA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44–57.
32. ChoudhuryM, JonscherKR, FriedmanJE (2011) Reduced mitochondrial function in obesity-associated fatty liver: SIRT3 takes on the fat. Aging (Albany NY) 3: 175–178.
33. HirscheyMD, ShimazuT, GoetzmanE, JingE, SchwerB, et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464: 121–125.
34. FritzKS, GalliganJJ, HirscheyMD, VerdinE, PetersenDR (2012) Mitochondrial acetylome analysis in a mouse model of alcohol-induced liver injury utilizing SIRT3 knockout mice. J Proteome Res 11: 1633–1643.
35. QiuX, BrownK, HirscheyMD, VerdinE, ChenD (2010) Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 12: 662–667.
36. StilesAR, McDonaldJG, BaumanDR, RussellDW (2009) CYP7B1: one cytochrome P450, two human genetic diseases, and multiple physiological functions. J Biol Chem 284: 28485–28489.
37. WuZ, MartinKO, JavittNB, ChiangJY (1999) Structure and functions of human oxysterol 7alpha-hydroxylase cDNAs and gene CYP7B1. J Lipid Res 40: 2195–2203.
38. van de SteegE, WagenaarE, van der KruijssenCM, BurggraaffJE, de WaartDR, et al. (2010) Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs. J Clin Invest 120: 2942–2952.
39. IngoliaNT, LareauLF, WeissmanJS (2011) Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 147: 789–802.
40. BrarGA, YassourM, FriedmanN, RegevA, IngoliaNT, et al. (2012) High-Resolution View of the Yeast Meiotic Program Revealed by Ribosome Profiling. Science
41. InsullWJr (2006) Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review. South Med J 99: 257–273.
42. LefebvreP, CariouB, LienF, KuipersF, StaelsB (2009) Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 89: 147–191.
43. HoutenSM, WatanabeM, AuwerxJ (2006) Endocrine functions of bile acids. EMBO J 25: 1419–1425.
44. WatanabeM, HoutenSM, MatakiC, ChristoffoleteMA, KimBW, et al. (2006) Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439: 484–489.
45. ThomasC, GioielloA, NoriegaL, StrehleA, OuryJ, et al. (2009) TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 10: 167–177.
46. ClaudelT, StaelsB, KuipersF (2005) The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Arterioscler Thromb Vasc Biol 25: 2020–2030.
47. MaK, SahaPK, ChanL, MooreDD (2006) Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest 116: 1102–1109.
48. CrosignaniA, Del PuppoM, LongoM, De FabianiE, CarusoD, et al. (2007) Changes in classic and alternative pathways of bile acid synthesis in chronic liver disease. Clin Chim Acta 382: 82–88.
49. VlahcevicZR, StravitzRT, HeumanDM, HylemonPB, PandakWM (1997) Quantitative estimations of the contribution of different bile acid pathways to total bile acid synthesis in the rat. Gastroenterology 113: 1949–1957.
50. ThomasC, PellicciariR, PruzanskiM, AuwerxJ, SchoonjansK (2008) Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov 7: 678–693.
51. PolsTW, NomuraM, HarachT, Lo SassoG, OosterveerMH, et al. (2011) TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab 14: 747–757.
52. MogensenM, SahlinK, FernstromM, GlintborgD, VindBF, et al. (2007) Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 56: 1592–1599.
53. MoothaVK, LindgrenCM, ErikssonKF, SubramanianA, SihagS, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267–273.
54. TannerCJ, BarakatHA, DohmGL, PoriesWJ, MacDonaldKG, et al. (2002) Muscle fiber type is associated with obesity and weight loss. Am J Physiol Endocrinol Metab 282: E1191–1196.
55. KimballSR, JeffersonLS, FaddenP, HaysteadTA, LawrenceJCJr (1996) Insulin and diabetes cause reciprocal changes in the association of eIF-4E and PHAS-I in rat skeletal muscle. Am J Physiol 270: C705–709.
56. PainVM, GarlickPJ (1974) Effect of streptozotocin diabetes and insulin treatment on the rate of protein synthesis in tissues of the rat in vivo. J Biol Chem 249: 4510–4514.
57. RamseyJC, SteeleWJ (1979) A method for visualizing and quantifying the total complement of free and membrane-bound ribosomes in rat liver. Anal Biochem 92: 305–313.
58. SaeedAI, BhagabatiNK, BraistedJC, LiangW, SharovV, et al. (2006) TM4 microarray software suite. Methods Enzymol 411: 134–193.
59. WuM, NeilsonA, SwiftAL, MoranR, TamagnineJ, et al. (2007) Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 292: C125–136.
60. FuruhashiM, TuncmanG, GorgunCZ, MakowskiL, AtsumiG, et al. (2007) Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447: 959–965.